Previous Close | 65.34 |
Open | 64.95 |
Bid | 62.43 x 200 |
Ask | 62.69 x 100 |
Day's Range | 62.20 - 65.00 |
52 Week Range | 25.98 - 110.25 |
Volume | |
Avg. Volume | 2,007,737 |
Market Cap | 6.539B |
Beta (5Y Monthly) | 0.68 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Cytokinetics Inc (NASDAQ:CYTK), a biopharmaceutical company focused on the discovery and development of next-generation therapeutics for muscle diseases, has reported an insider sale according to a recent SEC filing.
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]
Q4 2023 CytomX Therapeutics Inc Earnings Call